Post Sun Pharma

Rediff.com » News » Post Sun Pharma

News for Post Sun Pharma

News
Business

Cough syrup deaths: No state follows pharma safety norms

The Central Drugs Standard Control Organisation (CDSCO) will conduct testing, inspection and auditing of cough syrup manufacturers. IMAGE: Kindly note that this image has been posted for......

Infant dies in MP after taking Ayurvedic cough syrup

A five-month-old girl has died in Chhindwara district in Madhya Pradesh allegedly after consuming an Ayurvedic cough syrup and a medicinal powder, an official said on Friday. Image used only for......

Where The Deadly Cough Syrup Was Made

Sandwiched between a Hero MotoCorp showroom and a shop that hires out cooking utensils is a small, dingy building that's been locked up.The non-descript two-room building is a manufacturing unit of......

Cough Medicine Deaths: Rajasthan Suspends Drug Controller

The Rajasthan government has suspended the state drug controller and halted the distribution of medicines manufactured by Jaipur-based company Kaysons Pharma, officials said. Kindly note the image......

Rajasthan govt bans cough syrup after children's deaths

A generic cough syrup supplied to the Rajasthan government has been linked to the deaths of two children and others falling sick in the state over the last two weeks, prompting authorities to ban......

Seniors to Drive 25% of India's Pharma

'Once the 60-plus population hits 20 to 30 per cent of the country, the demand for elderly-care treatments will surge -- cardiac, metabolic, neurological, and musculoskeletal medicines are going to......

Strong therapies, JB to lift Torrent Pharma

A strong performance in the July–September quarter of 2025-26 (FY26) and expectations of growth from launches and acquisition-led synergies led to a 6.65 per cent jump in the share price of......

Sun Pharma Q2 net profit up 3% at Rs 3,118 cr

Sun Pharmaceutical Industries on Wednesday posted a 2.56 per cent increase in its consolidated net profit to Rs 3,118 crore for the second quarter ended September 30, aided by robust sales in India......

Trump's 100% tariff on pharma unlikely to hurt domestic industry: Experts

US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 is unlikely to have an immediate impact on Indian exports, as it will affect only......

Sensex, Nifty tank nearly 1% on selling in pharma, IT shares

Benchmark stock indices Sensex and Nifty tumbled nearly 1 per cent on Friday, marking their sixth consecutive day of decline, following heavy selling in pharma and IT shares as US President Donald......

Post Sun Pharma

News for Post Sun Pharma

Cough syrup deaths: No state follows pharma safety norms

Infant dies in MP after taking Ayurvedic cough syrup

Where The Deadly Cough Syrup Was Made

Cough Medicine Deaths: Rajasthan Suspends Drug Controller

Rajasthan govt bans cough syrup after children's deaths

Seniors to Drive 25% of India's Pharma

Strong therapies, JB to lift Torrent Pharma

Sun Pharma Q2 net profit up 3% at Rs 3,118 cr

Trump's 100% tariff on pharma unlikely to hurt domestic industry: Experts

Sensex, Nifty tank nearly 1% on selling in pharma, IT shares

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS